Current Indications for Helicobacter pylori Eradication Therapy

References

• Lee A. Peptic ulceration. H. pylori-induced ulcerogenesis—look to the host. Lancet 1993; 341: 280–1
   PubMed Web of Science ®Google Scholar
• Xiang Z, Censini S, Bayeli P F, Telford J L, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94–8
   PubMed Web of Science ®Google Scholar
• Covacci A, Censini B, Bugnoli M, Petracca K, Burroni D, Macchia G, et al. Molecular characterisation of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791–5
   PubMed Web of Science ®Google Scholar
• Boren T, Falk P, Roth H A, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892–5
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Farmery S M, Lindley I JD, Figura N, Peichl P, Tompkins D S. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945–50
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Wyatt J L, Sobala G M, Miller G, Tompkins D S, Primrose J N, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34: 1339–43
   PubMed Web of Science ®Google Scholar
• Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujihi N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric carcinoma patients. Int J Cancer 1994; 56: 55–80
   Google Scholar
• IARC Monographs on the evaluation of carcinogenic risks to humans. Some parasitic and bacterial infections. Lyon 1994; Vol 51
   Google Scholar
• Wotherspoon A C, Doglioni C, Diso T C, Pan L, Moochini A, DeBoni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7
   PubMed Web of Science ®Google Scholar
• Calvert R, Randerson J, Evans P, Cawkwell L, Lewis F, Dixon M F, et al. Genetic abnormalities during transition from Helicobacter pylori-associated gastritis to low-grade MALToma. Lancet 1995; 345: 26–7
   PubMedGoogle Scholar
• Parsonnet J, Hanson S, Rodriguez L, Gelb A B, Warnke E A, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. New Engl J Med 1994; 330: 1267–71
   PubMed Web of Science ®Google Scholar
• Stolte H, Eidt S. Healing gastric lymphoma by eradication of Helicobacter pylori. Lancet 1993; 342: 525
   Google Scholar
• Penston J G. Review article: Helicobacter pylori eradication—understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369–89
   PubMed Web of Science ®Google Scholar
• Talley N J. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174–83
   PubMed Web of Science ®Google Scholar
• McCarthy C, Patchett S, Collins R M, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114–19
   PubMed Web of Science ®Google Scholar
• Bayerdörffer E, Ritter M M, Hatz R, Brooks W, Stolte M. Ménétrier's disease and Helicobacter pylori. New Engl J Med 1993; 329: 60
   PubMed Web of Science ®Google Scholar
• Yamada T, Ahnen D, Alpers D H, Greenberg H B, Gray L, Josalyn K B, et al. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Dixon M F. Helicobacter pylori infection: role in peptic ulcer disease. Helicobacter pylori infection—pathophysiology, epidemiology and management, T C Northfield, M Mendall, P M Goggin. Kluwer Academic Publishers, London 1993; 75–87
   Google Scholar
• Tytgat G NJ, Dixon M F. Role of Helicobacter pylori in the pathogenesis of peptic ulcer disease. Practical implications for the clinician. Acid pump inhibitors and acid-related disorders, R H Hunt. Adis International, Osaka 1994; 79–97
   Google Scholar
• Laine L. The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy. Gastrointest Endosc 1995; 41: 77–9
   PubMedGoogle Scholar
• Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin N Am 1993; 22: 89–104
   PubMed Web of Science ®Google Scholar
• Solcia E, Villani L, Fiocca R, Luinetti O, Boldorini R, Trespi E, et al. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994; 29(Suppl 201)28–34
   Google Scholar
• Kuipers E J, Klinkenberg-Knol E C, Havu N, Festen H PM, Lamers C BHW, Jansen J BMJ, et al. Helicobacter pylori and development of atrophic gastritis during omeprazole maintenance therapy. Dutch Society for Gastroenterology Spring Meeting. March, 1995. Veldhoven, 111, (Abstract)
   Google Scholar